Ascend Wellness (OTCMKTS:AAWH) Upgraded to “Hold” at Zacks Research

Ascend Wellness (OTCMKTS:AAWH) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Tuesday,Zacks.com reports.

Ascend Wellness Stock Performance

Shares of Ascend Wellness stock opened at $0.57 on Tuesday. Ascend Wellness has a 12 month low of $0.26 and a 12 month high of $1.20. The firm has a market capitalization of $115.27 million, a P/E ratio of -0.98 and a beta of 1.22. The company has a current ratio of 1.92, a quick ratio of 1.14 and a debt-to-equity ratio of 133.34. The business has a fifty day simple moving average of $0.51 and a two-hundred day simple moving average of $0.59.

Ascend Wellness (OTCMKTS:AAWH) last released its earnings results on Wednesday, May 13th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.02). Ascend Wellness had a negative return on equity of 1,099.51% and a negative net margin of 23.61%. On average, equities analysts forecast that Ascend Wellness will post -0.32 earnings per share for the current fiscal year.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores.